Nonprofit · EIN 20-8774179
DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC
Also known as DELALI ATTIPOE
Tax-exempt · NEW YORK, NY 10006
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $6,221,917 | $6,349,740 | -$127,823 | $2,501,704 | $1,525,002 | $976,702 |
| December 31, 2023 | 990 | $4,350,936 | $4,172,304 | $178,632 | $1,819,761 | $715,236 | $1,104,525 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $6,193,831
- Program service revenue
- $0
- Investment income
- $28,086
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $3,670,704
- Compensation of officers, directors and key employees
- $592,831
- Other salaries and wages
- $810,473
- Salaries, compensation and benefits (total)
- $1,745,876
- Professional fundraising fees
- $0
- Accounting fees
- $14,500
- Occupancy
- $40,000
- Travel
- $135,626
- Program services (functional)
- $5,117,384
- Management and general (functional)
- $642,968
- Fundraising (functional)
- $589,388
Balance sheet and other
- Total assets, start of year
- $1,819,761
- Total assets, end of year
- $2,501,704
- Total liabilities, end of year
- $1,525,002
- Net assets, end of year
- $976,702
- Net assets without donor restrictions
- $964,225
- Net assets with donor restrictions
- $12,477
- Gross receipts
- $6,221,917
- Employees
- 12
- Volunteers
- 12
- Year formed
- 2007
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| DELALI ATTIPOE | EXECUTIVE DIRECTOR Officer | 40 | $239,914 | $71,070 |
| RACHEL COHEN | SENIOR ADVISOR, GLOBAL POL Officer | 40 | $213,183 | $68,664 |
| VISHAL GOYAL | SENIOR CLINICAL PROJECT AN Highest-paid employee | 40 | $146,409 | $31,015 |
| ILAN MOSS | HEAD OF MEDIA AND CONTENT Highest-paid employee | 40 | $156,476 | $13,940 |
| RON SYKES | SENIOR INDIVIDUAL GIVING MANAGER Highest-paid employee | 40 | $123,284 | $28,363 |
| SHIRLEY LEUNG | SENIOR HR BUSINESS PARTNER Highest-paid employee | 40 | $106,712 | $44,282 |
| LUIS PIZARRO | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| MEENA AHAMED | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| AFRICA STEWART | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| BENNETT SHAPIRO | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| KRISTINA TORGESON | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| DARIN PORTNOY | CHAIR OF THE BOARD Trustee or director, Officer | 3 | $0 | $0 |
| SHING CHANG | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| JOHN LAWRENCE | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
990 for the year ended December 31, 2023: 12 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| RACHEL COHEN | SENIOR ADVISOR, GLOBAL POLICY ADVOCACY & ACCESS Officer | 40 | $212,616 | $62,379 |
| COLIN FORSYTH | SENIOR RESEARCH AND PROJECT MANAGER Highest-paid employee | 40 | $113,013 | $58,932 |
| VISHAL GOYAL | SENIOR CLINICAL PROJECT AND MEDICAL MANAGER Highest-paid employee | 40 | $131,386 | $40,300 |
| ILAN MOSS | HEAD OF MEDIA AND CONTENT Highest-paid employee | 40 | $154,284 | $12,590 |
| DARIN PORTNOY | CHAIR OF THE BOARD Trustee or director, Officer | 3 | $0 | $0 |
| JOHN LAWRENCE | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| SHING CHANG | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| KRISTINA TORGESON | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| BENNETT SHAPIRO | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| AFRICA STEWART | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| MEENA AHAMED | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
| LUIS PIZARRO | BOARD MEMBER Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 40 RECTOR STREET 16TH FLOOR, NEW YORK, NY 10006-1751
- In care of
- % JANA ARMSTRONG
- Principal officer (990 for 2024)
- DARIN PORTNOY, 40 RECTOR STREET 16TH FLOOR, NEW YORK, NY 10006
- Signed the 990
- DELALI ATTIPOE, NORTH AMERICA DIRECTOR
- Phone
- (646) 215-7076
- Website
- WWW.DNDINA.ORG
- Return prepared by
- TAIT WELLER & BAKER LLP
Mission
THE MISSION OF DNDI NORTH AMERICA IS TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GLOBAL OBJECTIVES, IN PARTICULAR TO STRENGHTEN AND EXPAND DNDI'S SCIENTIFIC, POLICY ADVOCACY, FUNDRAISING, AND COMMUNICATIONS EFFORTS IN NORTH AMERICA BY (A) PROVIDING FOCUSED SUPPORT FOR SPECIFIC R&D PROJECTS AND BUSINESS/PARTNER DEVELOPMENT ACTIVITIES IN NORTH AMERICA;(B) ACHIEVING CONCRETE POLICY CHANGES IN NORTH AMERICA TO CREATE A MORE FAVORABLE ENVIRONMENT FOR NEEDS-DRIVEN R&D FOR NEGLECTED DISEASES;(C) MOBILIZING PUBLIC AND PRIVATE FUNDS IN NORTH AMERICA TO SUPPORT DNDI'S MISSION;(D) INCREASING DNDI'S PROFILE AND VISIBILITY IN NORTH AMERICA, THEREBY DRAWING GREATER PUBLIC ATTENTION TO THE NEED FOR NEGLECTED DISEASE R&D.
Program accomplishments
- GRANTS TO RESEARCH AND DEVELOPMENT FOR NEGLECTED DISEASES: DNDI NORTH AMERICA RAISES FUNDS TO SUPPORT DNDI'S RESEARCH AND DEVELOPMENT (R&D) ACTIVITIES IN ORDER TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GOAL OF DELIVERING 25 NEW TREATMENTS FOR NEGLECTED PATIENTS BY 2028 AND ESTABLISHING A ROBUST PIPELINE OF NEW POTENTIAL DRUG CANDIDATES. DNDI NOW HAS OVER 30 PROJECTS IN ITS PIPELINE, INCLUDING OVER 20 POTENTIAL NEW CHEMICAL ENTITIES (NCES), AND HAS DELIVERED 12 TREATMENTS OFR SIX DEADLY DISEASES THAT ARE ALREADY IN THE HANDS OF MILLIONS OF PATIENTS.Expenses $5,117,384 · grants $3,670,704
- RAISING PUBLIC AWARENESS AND ADVOCATING FOR NEGLECTED DISEASE R&D:AS PART OF ITS MISSION, DNDI ADVOCATES FOR ENHANCED POLITICAL LEADERSHIP, INCREASED RESOURCES, AND AN ENABLING POLICY ENVIRONMENT TO STIMULATE R&D FOR NEGLECTED DISEASES. DNDI NORTH AMERICA ACTIVELY ADVOCATES FOR SOUND POLICIES, PARTICULARLY IN THE UNITED STATES, THAT WILL ENABLE GREATER NEEDS-DRIVEN R&D, INCLUDING APPROPRIATE INCENTIVES AND FINANCING MECHANISMS, INNOVATIVE REGULATORY PATHWAYS THAT EXPEDITE ACCESS, AND OPEN INNOVATION APPROACHES TO INTELLECTUAL PROPERTY MANAGEMENT THAT ENSURE THE WIDEST POSSIBLE SHARING OF RESEARCH KNOWLEDGE AND DATA.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-8774179
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2007
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Health care (E05)
- Assets (IRS master file)
- $2,501,704
- Income (IRS master file)
- $6,221,917
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $6,221,917 | $6,349,740 | $2,501,704 | XML |
| 990 | December 2023 | $4,350,936 | $4,172,304 | $1,819,761 | XML |
| 990 | December 2022 | $3,931,942 | $3,853,071 | $1,155,455 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-8774179).
Questions about DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC
- What is the EIN of DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC?
- The employer identification number (EIN) of DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC is 20-8774179.
- Is DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
- Are donations to DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC?
- The 990 for the year ended December 31, 2024 names DARIN PORTNOY.
- Who are the officers and directors of DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC?
- The 990 for the year ended December 31, 2024 lists 14 people; 6 received compensation from the organization, the highest $239,914 (DELALI ATTIPOE, EXECUTIVE DIRECTOR).
- How much revenue does DRUGS FOR NEGLECTED DISEASESINITIATIVE NORTH AMERICA INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $6,221,917, expenses of $6,349,740 and total assets of $2,501,704 at year end.
Other nonprofits in NEW YORK
- HEALTHFIRST PHSP INC EIN 13-3783732 · last filed 990 for 2024
- THE NEW YORK AND PRESBYTERIAN HOSPITAL EIN 13-3957095 · last filed 990 for 2024
- NYU LANGONE HOSPITALS EIN 13-3971298 · last filed 990 for 2025
- MEMORIAL SLOAN-KETTERING CANCER CENTER EIN 91-2154267 · last filed 990 for 2024
- METROPLUS HEALTH PLAN INC EIN 13-4115686 · last filed 990 for 2024
- HEALTH INSURANCE PLAN OF GREATER NEW YORK EIN 13-1828429 · last filed 990 for 2024
- MOUNT SINAI HOSPITAL EIN 13-1624096 · last filed 990 for 2024
- VNS CHOICE EIN 13-3951057 · last filed 990 for 2024